RxDoctor Payments Data

Rachael Porter

Psychiatric/Mental Health · Milford, MANPI 1881267474

Payments from drug & device makers

$1,013in general payments, 2019–2025

Across 42 payments — averaging $24.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lundbeck LLC$184
  • AbbVie$126
  • Otsuka America Pharmaceutical, Inc.$120
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$118
  • Teva Pharmaceuticals USA, Inc.$98
  • Vanda Pharmaceuticals Inc.$88
  • plus $280 from 9 others

What the payments were for

  • Food & beverage$1,013100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,013 in reported general payments places this provider in the 75th percentile of 1,284 psychiatric/mental health providers in Massachusetts.

See all psychiatric/mental health providers in Massachusetts

Medicare billing

Part B allowed, 2024
$29,679
Medicare patients
33
Services billed
325

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole11$20,287
VyvanseLisdexamfetamine Dimesylate13$5,927
Aripiprazole23$3,373
Quetiapine Fumarate74$3,032
Lisdexamfetamine Dimesylate13$1,931
Trazodone Hcl85$1,183
Gabapentin43$938
Venlafaxine Hcl ErVenlafaxine Hcl66$838
Hydroxyzine Hcl48$761
Bupropion XlBupropion Hcl39$706
Buspirone Hcl31$526
Risperidone62$506
Sertraline Hcl66$487
Topiramate33$387
Mirtazapine13$377

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$120$20,28711 claims
Almatica Pharma LLCSertraline Hcl$41$48766 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,284 psychiatric/mental health providers in Massachusetts.

Other psychiatric/mental health in Milford

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →